CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shin Nippon Biomedical Laboratories Ltd Company Snapshot
Shin Nippon Biomedical Laboratories Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shin Nippon Biomedical Laboratories Ltd with three other companies in this sector in Japan: Linical Company Limited (2017 sales of 8.36 billion Japanese Yen [US$75.37 million] of which 90% was Cro Business), Sosei Group Corporation (18.90 billion Japanese Yen [US$170.49 million] of which 99% was Overseas Pharmaceutical Business), and Morishita Jintan Co., Ltd. (10.97 billion Japanese Yen [US$98.92 million] of which 71% was Health Care Business).

Sales Analysis. During the year ended March of 2017, sales at Shin Nippon Biomedical Laboratories Ltd were ¥17.24 billion (US$155.55 million). This is an increase of 16.9% versus 2016, when the company's sales were ¥14.75 billion. Despite this increase, sales are still below the level achieved in 2015, when Shin Nippon Biomedical Laboratories Ltd reported sales of ¥17.84 billion. Sales of Translational Research Project saw an increase that was more than double the company's growth rate: sales were up 155.5% in 2017, from ¥9.46 million to ¥24.17 million. Shin Nippon Biomedical Laboratories Ltd also saw significant increases in sales in Clinical Business (up 71.6% to ¥3.65 billion) . Not all segments of Shin Nippon Biomedical Laboratories Ltd experienced an increase in sales in 2017: sales of Other Businesses fell 44.4% to ¥4.07 million. (However, this segment's sales were only a very small portion of the company's overall sales). Shin Nippon Biomedical Laboratories Ltd also experienced decreases in sales in Police Medi (down 18.8% to ¥662.02 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shin Nippon Biomedical Laboratories Ltd
  Stock Performance Chart for Shin Nippon Biomedical Laboratories Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/15/2017): 528.00
(Figures in Japanese Yen)
1 Week 4.6%   13 Weeks -1.9%  
4 Weeks -24.0%   52 Weeks -9.0%  
 
Shin Nippon Biomedical Laboratories Ltd Key Data:
  Ticker: 2395 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 17,244,496,000
(Year Ending Jan 2018).
Employees: 1,506
  Currency: Japanese Yen Market Cap: 21,981,744,576
  Fiscal Yr Ends: March Shares Outstanding: 41,632,092
  Share Type: Common Closely Held Shares: 21,316,600
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.